Treatments & Clinical Trials

Stay informed about the latest breakthroughs in stem cell therapies and clinical trials that hold promise for a wide range of medical conditions. Explore how groundbreaking treatments and ongoing research are paving the way for the future of healthcare.

Blood Cancer Breakthroughs: How Expanded Cord Blood is Saving Lives

FDA-approved expanded cord blood therapies raise stem cell doses, speed neutrophil recovery, reduce infections, broaden donor access, and highlight the need to bank cord blood.

Overcoming Volume Limits: The Science of Expanding Cord Blood Cells

Ex vivo cord blood expansion boosts stem cell counts to speed engraftment, lower infection risk, and enable single‑unit adult transplants.

How New FDA Approvals Make Cord Blood Transplants Viable for Adults

FDA approvals and nicotinamide expansion make cord blood transplants viable for adults, speeding recovery and lowering infection risk.

Cord Blood Expansion: Why Your Baby's Stem Cells Can Now Treat Adults

Lab-expanded cord blood stem cells now enable adult transplants, shorten recovery, and make newborn banking a lasting medical resource.

The Evolution of Stem Cells: From Cord Blood to iPSC Technology

Overview of cord blood, cord tissue, placental cells, exosomes and iPSC advances, and why banking newborn cells may enable future regenerative therapies.

Are iPSCs the Key to Treating Parkinson’s and Autoimmune Diseases?

iPSCs can replace dopamine neurons in Parkinson’s and generate regulatory immune cells for autoimmune diseases; trials show promise despite cost, survival, and safety challenges.

iPSC Clinical Trials: The Latest Breakthroughs in Stem Cell Research

Overview of global iPSC clinical trials — Parkinson’s, eye, spinal and fertility therapies; safety, manufacturing challenges, and cord-blood/tissue banking.